Sotatercept
ATC C02KX06 · 8 markets · 22 records
CA 4 records · 4 strengths
SG 4 records · 2 strengths
- 60 mginjectionWINREVAIR® POWDER FOR SOLUTION FOR INJECTION 60MGWINREVAIR® POWDER FOR SOLUTION FOR INJECTION 60MG (VIAL ONLY)
- 45 mginjectionWINREVAIR® POWDER FOR SOLUTION FOR INJECTION 60MGWINREVAIR® POWDER FOR SOLUTION FOR INJECTION 60MG (VIAL ONLY)
HK 4 records · 1 strengths
Records without a stated strength · 1 WINREVAIR POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 45MG、WINREVAIR® POWDER FOR SOLUTION FOR INJECTION 60MG
AU 3 records · 3 strengths
- 72.5 mginjectionWINREVAIR sotatercept 45 mg powder for injection vial
- 55 mginjectionWINREVAIR sotatercept 45 mg powder for injection vial
Records without a stated strength · 1 WINREVAIR
GB 2 records · 2 strengths
ES 2 records · 2 strengths
TW 2 records · 1 strengths
Records without a stated strength · 1 WINREVAIR OD powder for solution for injection 50mg/mL、威納肺凍晶注射劑50毫克/毫升、穩納肺凍晶注射劑50毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 WINREVAIR
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.